138 related articles for article (PubMed ID: 9588575)
21. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM
Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123
[TBL] [Abstract][Full Text] [Related]
22. Positron emission tomography imaging-directed stereotactic neurosurgery.
Maciunas RJ; Kessler RM; Maurer C; Mandava V; Watt G; Smith G
Stereotact Funct Neurosurg; 1992; 58(1-4):134-40. PubMed ID: 1439330
[TBL] [Abstract][Full Text] [Related]
23. PET-FDG of pleomorphic xanthoastrocytoma.
Bicik I; Raman R; Knightly JJ; Di Chiro G; Fulham MJ
J Nucl Med; 1995 Jan; 36(1):97-9. PubMed ID: 7799091
[TBL] [Abstract][Full Text] [Related]
24. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
25. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
[TBL] [Abstract][Full Text] [Related]
27. Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomography.
Lilja A; Bergström K; Hartvig P; Spännare B; Halldin C; Lundqvist H; Långstrom B
AJNR Am J Neuroradiol; 1985; 6(4):505-14. PubMed ID: 2992257
[TBL] [Abstract][Full Text] [Related]
28. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
[TBL] [Abstract][Full Text] [Related]
29. [Amino acid metabolism in glioma patients studied with PET using 11C-methionine].
Kameyama M; Yoshimoto T
Nihon Rinsho; 1991 Jul; 49(7):1515-20. PubMed ID: 1886245
[No Abstract] [Full Text] [Related]
30. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours.
Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J
Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352
[TBL] [Abstract][Full Text] [Related]
31. PET: brain tumor biochemistry.
Roelcke U
J Neurooncol; 1994; 22(3):275-9. PubMed ID: 7760107
[TBL] [Abstract][Full Text] [Related]
32. Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma.
Kracht LW; Friese M; Herholz K; Schroeder R; Bauer B; Jacobs A; Heiss WD
Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):868-73. PubMed ID: 12692687
[TBL] [Abstract][Full Text] [Related]
33. [Uptake of DL-3-123I-iodo-alpha-methyltyrosine in recurrent brain tumors].
Guth-Tougelidis B; Müller S; Mehdorn MM; Knust EJ; Dutschka K; Reiners C
Nuklearmedizin; 1995 Apr; 34(2):71-5. PubMed ID: 7761277
[TBL] [Abstract][Full Text] [Related]
34. [MET-PET in low-grade glioma. Safe way to follow disease progression and treatment].
Smits A; Savitcheva I; Ribom D
Lakartidningen; 2007 Jan 31-Feb 6; 104(5):326-30. PubMed ID: 17328356
[No Abstract] [Full Text] [Related]
35. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
[TBL] [Abstract][Full Text] [Related]
36. Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging.
Manabe O; Hattori N; Yamaguchi S; Hirata K; Kobayashi K; Terasaka S; Kobayashi H; Motegi H; Shiga T; Magota K; Oyama-Manabe N; Nishijima K; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2015 May; 42(6):896-904. PubMed ID: 25647076
[TBL] [Abstract][Full Text] [Related]
37. [The basis of CT diagnosis. (2) Neuropathology for CT diagnosis-brain tumors (Part 2) (author's transl)].
Matsui T
Neurol Med Chir (Tokyo); 1981 Apr; 21(4):433-9. PubMed ID: 6165916
[No Abstract] [Full Text] [Related]
38. Images in neuro-oncology: anaplastic pleomorphic xanthoastrocytoma.
Baehring JM; Vives KP; Bannykh S
J Neurooncol; 2006 Sep; 79(2):151-2. PubMed ID: 16850109
[No Abstract] [Full Text] [Related]
39. FDG-PET in the selection of brain lesions for biopsy.
Hanson MW; Glantz MJ; Hoffman JM; Friedman AH; Burger PC; Schold SC; Coleman RE
J Comput Assist Tomogr; 1991; 15(5):796-801. PubMed ID: 1885797
[TBL] [Abstract][Full Text] [Related]
40. Cerebral glioma: evaluation with methionine PET.
Ogawa T; Shishido F; Kanno I; Inugami A; Fujita H; Murakami M; Shimosegawa E; Ito H; Hatazawa J; Okudera T
Radiology; 1993 Jan; 186(1):45-53. PubMed ID: 8380108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
